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pathogenic role in chronic inﬂammation and
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Laboratory, the Second Afﬁliated Hospital, School of Medicine, Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of ChinaComplement factor 5a (C5a) interaction with its receptor
(C5aR1) contributes to the pathogenesis of inﬂammatory
diseases, including acute kidney injury. However, its role in
chronic inﬂammation, particularly in pathogen-associated
disorders, is largely unknown. Here we tested whether the
development of chronic inﬂammation and renal ﬁbrosis
is dependent on C5aR1 in a murine model of chronic
pyelonephritis. C5aR1-deﬁcient (C5aR1-/-) mice showed a
signiﬁcant reduction in bacterial load, tubule injury and
tubulointerstitial ﬁbrosis in the kidneys following infection,
compared with C5aR1-sufﬁcient mice. This was associated
with reduced renal leukocyte inﬁltration speciﬁcally for
the population of Ly6Chi proinﬂammatory monocytes/
macrophages and reduced intrarenal gene expression
of key proinﬂammatory and proﬁbrogenic factors in
C5aR1-/- mice following infection. Antagonizing C5aR1
decreased renal bacterial load, tissue inﬂammation and
tubulointerstitial ﬁbrosis. Ex vivo and in vitro studies
showed that under infection conditions, C5a/C5aR1
interaction upregulated the production of proinﬂammatory
and proﬁbrogenic factors by renal tubular epithelial cells
and monocytes/macrophages, whereas the phagocytic
function of monocytes/macrophages was down-regulated.
Thus, C5aR1-dependent bacterial colonization of the
tubular epithelium, C5a/C5aR1-mediated upregulation
of local inﬂammatory responses to uropathogenic E. coli
and impairment of phagocytic function of phagocytes
contribute to persistent bacterial colonization of the
kidney, chronic renal inﬂammation and subsequent
tubulointerstitial ﬁbrosis.
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U rinary tract infections (UTIs) remain among the mostcommon human infectious diseases worldwide(w150–250 million cases globally per year).1–3 UTIs
present as a wide spectrum of diseases, including bladder
infection (cystitis), kidney infection (pyelonephritis), and
associated renal damage (e.g., renal ﬁbrosis). Kidney infection
is usually caused by ascending infections of the lower urinary
tract. Recurrent or long-standing (chronic) kidney infections
can result in renal tubulointerstitial ﬁbrosis, which is a much
more common situation in children or in patients with dia-
betes mellitus or urinary obstructions. Although antibiotics
are available to treat the disease, a number of challenges
remain, including frequent recurrence, persistence of infec-
tion, and the increasing risk for resistance to antibiotics.1,4
It is therefore imperative to improve our current understand-
ing of the pathogenesis of UTIs and develop novel therapeutic
strategies to improve current treatment.
Uropathogenic Escherichia coli (UPEC) is the primary cause
of UTIs, and most UPEC express a variety of ﬁmbriae (e.g., P,
type 1) that enable them to bind and invade uroepithelial
cells.5 Although innate immunity plays an essential role in the
ﬁrst line of host defense against pathogens, in UTIs most
human UPEC strains are resistant to complement-mediated
killing.6,7 Bacteria-mediated acute inﬂammatory responses
can cause renal tissue inﬂammation and epithelium destruc-
tion, allowing bacteria to enter the underlying tissue,8–10 and
persistent bacterial colonization and chronic inﬂammation
can lead to tubular atrophy and tubulointerstitial ﬁbrosis.11
C5a receptor 1 (C5aR1) is a 350–amino acid glycoprotein
and member of the G-protein–coupled receptor superfamily
of proteins that is expressed in myeloid cells (e.g., neutrophils
and monocytes/macrophages [MO/MFs]) and nonmyeloid
cells, including renal tubular epithelial cells.12 The well-known
ligand for C5aR1 is C5a (also called an anaphylatoxin), which
is a 74–amino acid glycopolypeptide fragment generated
during complement activation by cleavage of complement C5.
The interaction of C5aR1 with C5a mediates a broad spectrumKidney International (2016) 90, 540–554
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permeability, recruitment of leukocytes to sites of injury or
infection, generation of cytotoxic oxygen radicals (by gran-
ulocytes), and generation of proinﬂammatory mediators (by
myeloid and nonmyeloid cells). A large body of research has
demonstrated that C5a/C5aR1 signaling contributes to the
pathogenesis of a wide range of inﬂammatory pathologies,
including renal disorders.12–14 Furthermore, there is compel-
ling evidence from sepsis studies indicating that C5a/C5aR1
signaling can provide counterregulatory effects in host defense
through impairment of innate immune cell function and
induce excessive inﬂammatory responses.15 Pathogenic roles
for C5a/C5aR1 signaling have also been reported in a number
of other animal models of infectious disease, such as malaria,
acute pneumococcal otitis media, and gram-negative bacter-
emia.16–18 However, the roles for C5aR1 in chronic kidney
disease, particularly under conditions of infection, are largely
unknown.
Given that (i) C5aR1 is expressed in renal resident and
inﬂammatory cells and is up-regulated under pathological
conditions,12,19–22 (ii) C5a/C5aR1 signaling is a strong driver
of tissue inﬂammation,13,14 and (iii) C5a/C5aR1 signaling has
a negative impact on phagocyte function,23,24 together with the
pathological features of chronic kidney infection (i.e., persis-
tent bacterial colonization, tissue inﬂammation, and tubu-
lointerstitial ﬁbrosis),11,25 we hypothesized that C5aR1 may
play a pathogenic role in chronic kidney infection. To test this
hypothesis, we used a well-established murine model of
chronic pyelonephritis induced by the UPEC strain IH11128
and C5aR1-deﬁcient (C5aR1-/-) mice, as well as a C5aR1
antagonist, to determine the role of C5aR1 in chronic kidney
infection (i.e., bacterial load, tissue inﬂammation, and tubu-
lointerstitial ﬁbrosis). We also investigated the cellular basis of
the C5a/C5aR1 axis, which contributes to the pathogenesis of
chronic kidney infection, by examining the inﬂuence of C5aR1
on cellular inﬁltration of the kidney following renal infection.
In addition, we measured the effects of C5a/C5aR1 on the
production of proinﬂammatory and proﬁbrogenic factors by
primary cultured renal tubular epithelial cells (RTECs) and
MO/MFs in response to bacterial stimulation and assessed the
impact of C5a/C5aR1 on the phagocytic function of MO/MFs.
Our data demonstrate that following infection, early and
persistent bacterial colonization, renal inﬂammation, and
tubulointerstitial ﬁbrosis are dependent on C5aR1, suggesting
that C5aR1 facilities the pathogenesis of chronic kidney
infection by enhancement of bacterial colonization of tubular
epithelium, promotion of local inﬂammatory responses, and
impairment of phagocytic function of MO/MFs.
RESULTS
C5aR1-/- mice have reduced bacterial load in the kidney and
bladder following bladder inoculation with UPEC
Previous studies in a murine model of chronic kidney
infection induced by IH11128 have shown that bacterial
colonization of the kidney can be detected at 1 to 2 days
after infection and persist for months.11 We thereforeKidney International (2016) 90, 540–554assessed bacterial load in the kidney and bladder of wild-
type (WT) and C5aR1-/- mice at three stages of infection,
namely, early (day 2), intermediate (day 14), and late (day
56) after infection, by counting bacterial colony-forming
units (CFUs) recovered from kidney or bladder tissue
samples on agar plates.26 After bacterial inoculation into the
bladder (postinfection), bacterial colonies in the kidney and
bladder peaked at day 1 to day 2; afterwords, there was a
trend. However, C5aR1-/- mice had signiﬁcantly lower bac-
terial colony counts in the kidneys at all time points after
infection (day 2, day 4, and day 56) and in the bladder at
day 2 and day 14 after infection compared with WT mice
(Figure 1a and b). We also performed ﬂuorescence micro-
scopy analysis of bacterial colonies in infected kidney tissues
from WT and C5aR1-/- mice at day 2 after inoculation with
ﬂuorescence-labeled bacteria. Consistent with the results of
the agar plate assay, bacterial colonies in the renal tubular
epithelium were signiﬁcantly lower in C5aR1-/- mice
compared with in WT mice (Figure 1c and d). Collectively,
these data demonstrate that C5aR1 deﬁciency reduces bac-
terial load in the kidney and bladder.
C5aR1 deﬁciency attenuates renal pathology following
infection
TheUPEC strain IH11128 used in this study lacks expression of
P ﬁmbriae; therefore, they do not cause severe tissue destruc-
tion. However, they do mediate the chronic inﬂammatory
process within the renal parenchyma, leading to progressive
tissue injury.11 We therefore assessed the renal histopathology
of infected WT and C5aR1-/- mice at different stages of infec-
tion. Renal histopathological changes, including cellular inﬁl-
tration, tubular damage, and interstitial inﬂammation, were
observed at all time points after infection. Tubular atrophy and
interstitial inﬂammation became more apparent at the later
time points. The changes were predominantly located within
the corticomedullary junction but were also observed in other
areas (e.g., the outer cortex and inner medulla). On the basis of
these changes, we performed histological scoring of periodic
acid–Schiff– and hematoxylin and eosin–stained kidney sec-
tions from individual mice in the WT and C5aR1-/- groups.
Compared with WTmice, C5aR1-/- mice exhibited attenuated
renal histopathological lesions at all time points (days 2, 14, and
56) (Figure 2a and b). We also assessed renal function in WT
and C5aR1-/- mice after infection by measuring blood urea
nitrogen (BUN) levels. Blood urea nitrogen was not signiﬁ-
cantly elevated in all infectedmicewhen comparedwith normal
mice, but there was a trend toward increased blood urea ni-
trogen in WT mice at the late time point after infection
(Figure 2c). These data demonstrate that renal histopatholog-
ical lesions and late functional impairment were reduced in
C5aR1-/- mice after infection.
C5aR1 deﬁciency inﬂuences the extent and phenotype of
cellular inﬁltrates in the kidney in response to infection
Cellular inﬁltration was further analyzed by ﬂow cytometry
and immunohistochemistry at early and intermediate time541
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Figure 1 | C5aR1-/- mice have reduced bacterial load in the kidney and bladder after bladder inoculation with urethropathogenic
Escherichia coli (UPEC). Bacterial loads in the kidney (a) and bladder (b) from wild-type (WT) and C5aR1-/- mice were examined at days 2, 14, and
56 after infection. Each dot represents colony-forming units (CFUs) recovered from an individual mouse and is shown as average CFUs from 2
replicate agar plates. Data were analyzed by Student’s t test (n¼ 6–11 mice per group). ***P< 0.001. (c) Representative ﬂuorescence microscope
images of kidney sections from WT and C5aR1-/- mice at day after infection, taken at the corticomedullary junction and showing bacterial
colonization of renal tubular epithelium (arrows) (blue ¼ 4,6-diamino-2-phenylindole, green ¼ lotus tetragonolobus lectin, red ¼ bacteria)
(bar ¼ 25 mm). (d) Quantiﬁcation of bacterial colonies in the kidneys of infected WT and C5aR1-/- mice. Data were analyzed by Student’s t test
(60 viewing ﬁelds [200 magniﬁcation] from 4 mice per group). ***P < 0.001. A representative of 2 independent experiments is shown.
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cytometry analysis of renal cell suspensions showed that when
compared with WT, C5aR1-/- kidneys had lower numbers of
leukocytes (CD45þ) at day 2 after infection and a lower
proportion of MO/MFs (Ly6G-CD11bþ) within CD45þ cells
at day 14 after infection (Figure 3a–c). In addition, compared
with WT, C5aR1-/- kidneys had a lower Ly6Chi population
and reduced ratios of Ly6Chi to Ly6Clo populations within the
MO/MFs (Ly6G-CD11bþ) compartment at both day 2 and
day 14 after infection (Figure 3a, d, and e). However, C5aR1-/-
kidneys had a similar proportion of neutrophils (Ly6Gþ)
within CD45þ cells compared with WT kidneys at day 2 and
day 14 after infection (Figure 3a and f). Immunohisto-
chemistry showed that when compared with WT, C5aR1-/-
kidneys had lower numbers of CD45þ cells (day 2 after542infection) and F4/80þ cells (day 14 after infection) than WT
kidneys (Figure 3g–3i), which is in agreement with the results
of ﬂow cytometry analysis. Collectively, these results indicate
that C5aR1 deﬁciency not only caused a general reduction in
cellular inﬁltration and MO/MF accumulation but also spe-
ciﬁcally reduced inﬂammatory monocytes’ inﬁltration of the
kidney in response to renal infection. However, C5aR1 deﬁ-
ciency did not cause a reduction of neutrophil inﬁltrate at the
time points studied in this model.
C5aR1 deﬁciency attenuates renal tissue inﬂammation and
ﬁbrogenesis following renal infection
Persistent tissue inﬂammation and ﬁbrogenesis play an
important role in the progression of chronic kidney disease.
We therefore used semiquantitative reverse transcriptaseKidney International (2016) 90, 540–554
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and ﬁbrogenesis of WT and C5aR1-/- mice following renal
infection. Gene expression of proinﬂammatory cytokines
(tumor necrosis factor-a [TNF-a] and interleukin-1b
[IL-1b]), chemokines (keratinocyte-derived protein chemokine
[KC], monocyte chemoattactant protein-1 [MCP-1]), chemo-
kine receptor (C-C motif chemokine receptor 2 [CCR2]), and
proﬁbrogenic factors (transforming growth factor-b [TFG-b]
and platelet-derived growth factor [PDGF]) was signiﬁcantly
reduced in C5aR1-/- mice compared with in WT mice at all
time points studied (Figure 4a–4c). In contrast, gene
expression of antiﬁbrogenic factor (hepatocyte growth factor)
was signiﬁcantly higher in C5aR1-/- mice than in WTmice at
day 2 and day 14 after infection (Figure 4d). Collectively, these
results indicate that absence of C5aR1 attenuates renal tissue
inﬂammation and ﬁbrogenesis following renal infection.
Less severe renal ﬁbrosis develops in C5aR1-/- mice after
infection
To further investigate the impact of C5aR1 on the development
of renal ﬁbrosis, we assessed the extent of collagen deposition
and extracellular matrix production in kidneys from WT and
C5aR1-/- mice following renal infection. Sirius red staining was
performed on kidney sections at day 14 and day 56 after
infection. Compared with WT kidneys, C5aR1-/- kidneys
exhibited a signiﬁcant reduction of Sirius red staining
(Figure 5a and b). We also examined gene expression of several
major extracellular matrix and cytoskeletal proteins in kidneys
from WT and C5aR1-/- mice at day 14 and day 56 after infec-
tion using semiquantitative reverse transcriptase polymerase
chain reaction. Intrarenal expression of mRNA encoding for
extracellular matrix proteins (collagen I and ﬁbronectin) and
cytoskeleton proteins (a-smooth muscle and vimentin) was
signiﬁcantly reduced in C5aR1-/- mice compared with in WT
mice. In contrast, C5aR1-/- mice had signiﬁcantly higher levels
of mRNA for collagen IV (which is required for renal tubular
epithelial cell structural and functional integrity27) than did
WT mice (Figure 5c). Taken together, these ﬁndings indicate
that C5aR1 deﬁciency protects mice from renal ﬁbrosis and
parenchymal loss following renal infection.
Antagonizing C5aR1 reduces renal inﬂammation and ﬁbrosis
following renal infection
In addition to studying C5aR1-/- mice, we used a well-known
C5aR1 antagonist (PMX53)28 to assess whether this
approach can curtail renal infection, tissue inﬂammation, and
ﬁbrosis. WTmice were administered PMX53 or control agent
daily for 13 days. Consistent with observations made inFigure 2 | C5aR1 attenuates renal pathology following renal infectio
sections from noninfected and infected wild-type (WT) and C5aR1-/- mic
junction. Arrows show renal tubular lesions. Bar ¼ 100 mm. (b) Histologi
individual mouse. Data were analyzed by Student’s t test (n ¼ 5 or 6 m
infected WT and C5aR1-/- mice at days 2, 14, and 56 after infection. The do
analyzed by Student’s t test (n ¼ 6–11 mice per group). *P < 0.05. A re
544C5aR1-/- mice, renal histopathology, tissue inﬂammation/
ﬁbrogenesis, collagen deposition, and bacterial load were
signiﬁcantly reduced in the kidneys of PMX53-treated mice
compared with in the control group at day 14 after infection
(Figure 6a–e). These results further conﬁrmed the pathogenic
role for C5aR1 in this model and also suggest a therapeutic
potential for targeting C5aR1 in chronic kidney infection. To
further investigate whether the major effects of C5aR1 on
chronic inﬂammation and renal ﬁbrosis are dependent on the
initial impact of C5aR1 or the subsequent responses, we per-
formed an additional set of in vivo experiments. WTmice were
given PMX53 or control agent at the following different stages
of infection: (i) starting at day 0 (2 hours before the inocula-
tion) and continuing up to day 2 (early administration) and (ii)
starting at day 3 after the inoculation and continuing up to day
13 (late administration). Early bacterial colonization was
assessed at day 3 after infection following early administration.
Mice that received PMX53 exhibited signiﬁcantly fewer CFUs
in the kidney compared with mice that received control agent
(Figure 6f). Chronic injury was assessed at day 14 after infec-
tion. Both early and late administration of PMX53 reduced
renal ﬁbrosis and tissue bacterial load, but early administration
led to amore profound reduction compared with in the control
group (Figure 6g–i). These results suggest that the initial
impact of C5aR1 plays an important role in the limit of bac-
terial load and subsequent chronic inﬂammation and renal
ﬁbrosis.
C5a/C5aR1 interaction ampliﬁes bacteria-induced production
of proinﬂammatory and proﬁbrogenic factors by RTECs and
MO/MFs
Our in vivo data presented in this article suggest a critical role
for C5aR1 in renal tissue inﬂammation and ﬁbrogenesis
following renal infection. To explore the cellular basis for the
C5a/C5aR1 axis contributing to renal tissue inﬂammation
and ﬁbrogenesis, we used primary cell culture systems for
RTECs and MO/MFs and then used reverse transcriptase
polymerase chain reaction to assess the effects of C5a/C5aR1
interactions on production of proinﬂammatory and proﬁ-
brogenic factors by these cells in response to bacterial stim-
ulation. Incubation with C5a alone led to only a small
increase in proinﬂammatory and proﬁbrogenic factor mRNA
expression by RTECs and MO/MFs. Incubation with heat-
killed UPEC alone clearly increased mRNA expression of
proinﬂammatory factors (i.e., tumor necrosis factor-a,
interleukin-1b, monocyte chemoattactant protein-1, and
keratinocyte-derived protein chemokine) by RTECs and MO/
MFs. In the presence of C5a, mRNA expression levels forn. (a) Representative images of periodic acid-Schiff–stained kidney
e at days 2, 14, and 56 after infection, taken at the corticomedullary
cal scores in the mice illustrated in panel (a). Each dot represents an
ice per group). ***P < 0.001. (c) Blood urea nitrogen (BUN) levels in
tted line on the graph represents BUN level in normal mice. Data were
presentative of 2 independent experiments is shown.
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Figure 3 | C5a receptor (C5aR) deﬁciency inﬂuences the extent and phenotype of cellular inﬁltrates in the kidneys following renal
infection. Renal inﬂammatory cell inﬁltration was analyzed in infected wild-type (WT) and C5aR1-/- mice at days 2 and 14 after infection by ﬂow
cytometry. (a) Stepwise gating strategy used in ﬂow cytometric analysis of leukocytes, neutrophils, monocytes/macrophages (MO/MFs), and
Ly6chi MO/MFs in kidney tissues. (b–f) Quantiﬁcation of leukocytes (CD45þ), MO/MF (Ly6G-CD11bþ), Ly6chi population, and ratio of Ly6chi to
Ly6clo populations within the Ly6G-CD11bþ compartment and neutrophils (Ly6Gþ), respectively. Each dot represents an individual mouse. Data
were analyzed by Student’s t test (n ¼ 5 mice per group). **P < 0.05. ***P < 0.005. (g–i) Immunohistochemistry. (g) Representative (Continued)
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Figure 3 | (Continued) images of CD45- and F4/80-stained kidney sections from infected WT and C5aR1-/- mice (n ¼ 4 mice per group). Arrows
show positively stained cells. Bar ¼ 100 mm. (h,i) Quantiﬁcation of CD45þ and F4/80þ cells. Data were analyzed by Student’s t test (40–50
viewing ﬁelds [0.04 mm2 per ﬁeld] from 4 mice per group). ***P < 0.001. A representative of 2 independent experiments is shown.
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RTECs and MO/MFs compared with in the absence of C5a.
Combined heat-killed UPEC and C5a treatment also
increased mRNA expression of proﬁbrotic factors (i.e.,
transforming growth factor-b and platelet-derived growth
factor) by RTECs and MO/MFs compared with heat-killed
UPEC or C5a treatment alone (Table 1). Thus, our data
indicate that engagement of C5aR1 ampliﬁes UPEC-induced
production of proinﬂammatory and proﬁbrogenic factors by
RTECs and MO/MFs.
C5a/C5aR1 interaction has a negative effect on the phago-
cytic function of phagocytes
In addition to the effects on cytokine production by MO/
MFs, we assessed the impact of C5a/C5aR1 interactions on
the ability of phagocytes to kill bacteria by using primary
MO/MFs prepared from WTmice. MO/MFs were pretreated
with C5a (10 nM or 50 nM) for 4 hours and then used for
bacterial uptake and intracellular killing assays. The uptake of
UPEC was comparable in the control and C5a-treated MO/
MFs, whereas survival of intracellular UPEC was signiﬁcantly
increased in C5a-treated MO/MFs compared with in the
control group, indicating that C5a treatment caused546impairment of the bactericidal activity of MO/MFs but had
no apparent effect on bacterial uptake (Figure 7).DISCUSSION
Our current understanding of the roles of C5a/C5aR1 in the
pathogenesis of kidney disease is primarily based on studies
in acute or non–pathogen-related injury. In this study we
used a well-characterized murine model of ascending UTI to
investigate the role of C5aR1 in chronic kidney injury.
Our data demonstrate that C5aR1 deﬁciency or blockade
not only reduces renal bacterial load at all stages of infection
but also attenuates tissue inﬂammation and tubulo-
interstitial ﬁbrosis, suggesting a pathogenic role for C5aR1 in
experimental chronic kidney infection. Mechanistic studies
suggest that C5aR1-mediated bacterial colonization of
tubular epithelium, persistent local inﬂammatory responses,
and impairment of the phagocytic function of MO/MFs
could contribute to the pathogenesis of chronic kidney
infection. Thus, our data further support the notion that
excessive or persistent tissue inﬂammation represents an
important pathogenic mechanism in acute and chronic
kidney infection.8,10,11Kidney International (2016) 90, 540–554
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Figure 4 | Absence of C5a receptor (C5aR1) reduces intrarenal gene expression of proinﬂammatory and proﬁbrogenic factors in
response to renal infection. Relative mRNA levels of proinﬂammatory and proﬁbrogenic factors in infected kidney tissues from wild-type WT
and C5aR1-/- mice at the indicated stages of infection by quantitative reverse transcriptase polymerase chain reaction. (a) Proinﬂammatory
cytokines (tumor necrosis factor-a [TNF-a] and interleukin-6 [IL-6]). (b) Proinﬂammatory chemokines (keratinocyte-derived protein (Continued)
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C5aR1 deﬁciency or blockade C5aR1 reduced bacterial load at
all stages of infection studied, even at the early stage of
infection (day 2 or 3 after inoculation). This suggests that
C5aR1 could have an impact on early UPEC colonization of
renal tract epithelium. In support of this hypothesis, our
recent work (in a separate study) has revealed that bacterial
adhesion and tissue colonization mediated by the expression
of mannosyl residues—a ligand for type 1 ﬁmbriae that we
detected on the luminal surface of the renal tubular and
bladder epithelium—is increased by C5aR1-induced signaling
(unpublished data). In addition to the impact on bacterial
colonization, in the present study, we have also found that
treatment of MO/MFs with C5a signiﬁcantly reduced their
bactericidal activity, suggesting that C5a/C5aR1 interaction
has a negative regulatory effect on the phagocytic function of
MO/MFs, which is consistent with the well-recognized phe-
nomenon of C5a/C5aR1 signaling being a strong driver of
inﬂammation and having a negative impact on the phagocytic
function of phagocytes.24,29 Therefore, C5a/C5aR1 interac-
tion–mediated enhancement of UPEC adhesion/colonization
of renal tract epithelium (possibly through upregulation
of expression of mannosyl residue on the luminal surface of
renal tubular and bladder epithelium) and impairment of
phagocytic function of phagocytes could contribute to the
early and persistent bacterial colonization of the kidney that
we observed in this model.
Another important observation from this study is that
following renal infection, C5aR1 deﬁciency or blockade
resulted in a reduction in renal tissue inﬂammation (i.e.,
cellular inﬁltration, tubular atrophy, and intrarenal gene
expression of proinﬂammatory factors). These ﬁndings
strongly suggest that C5aR1 has a critical role in upregulating
local inﬂammatory responses to UPEC, which contributes to
chronic inﬂammation of the kidney and development of renal
scarring. To explore the cellular basis of the C5a/C5aR1 axis
contributing to tissue inﬂammation, we examined the impact
of C5aR1 on inﬂammatory cell inﬁltration and found that
C5aR1-/- deﬁciency not only reduced the accumulation of
leukocytes and MO/MFs but speciﬁcally reduced the popu-
lation of Ly6Chi proinﬂammatory MO/MFs following renal
infection. These ﬁndings suggest that C5aR1 not only pro-
motes chemotaxis of leukocytes but also plays an important
role in modulating the phenotype of inﬁltrating cells. C5aR1
deﬁciency resulting in overall inhibition of cellular inﬁltration
and accumulation of proinﬂammatory MO/MFs could
contribute to the control and resolution of local inﬂammation.
In addition to cellular inﬁltration, we also examined the
impact of C5a/C5aR1 interaction on cellular responses toFigure 4 | (Continued) chemokine [KC] and monocyte chemoattactant pr
(CCR2). (c) Proﬁbrogenic factors (transforming growth factor-b [TGF-b] an
(HGF). Each dot represents an individual mouse and is shown as the me
representative of 3 separate cDNA preparations tested in duplicate for e
expression level in normal kidney tissue. Data were analyzed by Student’
representative of 2 independent experiments is shown.
548UPEC. We focused on RTECs and MO/MFs, as both types of
cells express C5aR1 and also are important sources of
proinﬂammatory and proﬁbrogenic factors in the kidney. Our
ﬁndings that C5a stimulation up-regulated UPEC-induced
production of proinﬂammatory and proﬁbrogenic factors by
cultured RTECs and MO/MFs suggest that (i) engagement of
C5aR1 on both inﬂammatory and renal parenchymal cells
could contribute to local tissue inﬂammation and (ii) the
additive effect of C5a and UPEC on cytokine production by
RTECs and MO/MFs could be explained by the interaction of
C5aR1 and Toll-like receptor signaling, as suggested by a
previous study in a lipopolysaccharide-induced cytokine
production model.30
Additionally, our study found that C5aR1 has a big impact
on the development of renal ﬁbrosis. Less severe renal tubular
interstitial ﬁbrosis developed in C5aR1-/- mice than in WT
mice following renal infection. The pathogenesis of renal
ﬁbrosis is complex, as multiple cell types and molecular
pathways are involved. However, it is becoming increasingly
clear that the inﬂammatory microenvironment of the kidney
after sustained injury is a key determinant of the dynamic
balance between tissue destruction (tubular atrophy and
interstitial ﬁbrosis) and repair (tubular cell growth and res-
olution of renal inﬂammation and ﬁbrosis).31,32 Previous
studies have shown that increased intrarenal expression of
proinﬂammatory and proﬁbrogenic factors are strongly
associated with renal ﬁbrosis.32–34 Our ﬁnding of an associ-
ation of reduced renal ﬁbrosis with signiﬁcant reduction of
renal expression of an array of proinﬂammatory and proﬁ-
brogenic factors in C5aR1-/- mice suggests that C5a/C5aR1-
mediated proinﬂammatory and proﬁbrotic responses could
contribute to the pathogenesis of renal ﬁbrosis. In addition,
previous studies have shown that the phenotype of the in-
ﬂammatory cell inﬁltrate has an impact on chronic renal
inﬂammation and ﬁbrosis, suggesting that renal Ly6Chi
proinﬂammatory MO/MFs have proﬁbrotic effects. Our
ﬁndings that C5aR1-/- deﬁciency speciﬁcally reduced the
population of Ly6Chi proinﬂammatory MO/MFs following
renal infection suggest that C5a/C5aR1 could contribute to
the development of renal ﬁbrosis by modulating the pheno-
type of inﬁltrating leukocytes.
Intrarenal gene expression proﬁles from this study revealed
that absence of C5aR1 not only reduced the expression of
proinﬂammatory and proﬁbrogenic factors and mesenchymal
markers but also led to increased expression of hepatocyte
growth factor and collagen IV following renal infection. He-
patocyte growth factor was suggested as an important anti-
ﬁbrotic factor in renal ﬁbrosis, promoting renal cell survival,
proliferation, migration, and tubulogenesis and directlyotein-1 [MCP-1]) and MCP-1 receptor C-C motif chemokine receptor 2
d platelet-derived growth factor [PDGF]). (d) Hepatocyte growth factor
an of 2 replicate polymerase chain reaction results. Data were
ach mouse. The dotted line on the graph represents the gene
s t test (n ¼ 6 mice per group). *P < 0.05, **P < 0.005, ***P < 0.001. A
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Figure 5 | Less severe renal ﬁbrosis develops in C5a receptor 1–deﬁcient (C5aR1-/-) mice after infection. (a) Representative images of Sirius
red–stained kidney sections from wild-type (WT) and C5aR1-/- mice at days 14 and 56 after infection, taken at the corticomedullary junction.
Arrows show positively stained area. Bar ¼ 200 mm. (b) Quantiﬁcation of collagen deposition (Sirius red staining) in kidney sections of the mice
in panel (a). Data were analyzed by Student’s t test (20–30 viewing ﬁelds [1.92 mm2 per ﬁeld] from 4 mice per group). ***P < 0.001. (c)
Semiquantitative analysis of mRNA expression of extracellular matrix and cytoskeletal proteins in infected WT and C5aR1-/- kidney tissue (n ¼ 6
mice per group). Each dot represents an individual mouse and is shown as the mean of 2 replicate polymerase chain reaction results. The
dotted line on the graph represents the gene expression level in normal kidney tissue. Data were analyzed by Student’s t test. **P < 0.005,
***P < 0.001. A representative of 2 independent experiments is shown.
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Figure 6 | Antagonizing C5a receptor (C5aR1) reduces renal inﬂammation and ﬁbrosis following renal infection. (a–e) Wild-type mice
were administered PMX53 or control (ctrl) agent daily for 13 days starting on the day of induction of renal infection. Assessment of chronic
inﬂammation, renal ﬁbrosis, and renal bacterial load was performed at day 14 after infection. (a) Representative images of periodic acid–Schiff
(PAS)- or Sirius red (SR)-stained kidney sections taken at the corticomedullary junction. Arrows show tubular lesions or areas positively (Continued)
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Figure 6 | (Continued) stained with Sirius red. Bar ¼ 200 mm. (b) Histological scores in the mice illustrated in panel (a). Each dot represents an
individual mouse. Data were analyzed by Student’s t test (n ¼ 5 mice per group). (c) Quantiﬁcation of collagen deposition (Sirius red staining) in
kidney sections of the mice in panel (a). Data were analyzed by Student’s t test (20 to 30 viewing ﬁelds [1.92 mm2 per ﬁeld] from 5 mice per
group). (d) Bacterial loads in the kidneys. Each dot represents colony-forming units recovered from an individual mouse and is shown as
average colony-forming units from 2 replicate agar plates. (e) Semiquantitative analysis of mRNA expression of extracellular matrix and
cytoskeletal proteins in infected kidney tissue. Each dot represents an individual mouse and is shown as the mean of 2 replicate polymerase
chain reaction results. (d,e) Data were analyzed by Student’s t test (n ¼ 5 mice per group). A representative of 2 independent experiments is
shown. (f–i) Wild-type mice were given PMX53 or control agent at different stages of infection starting at day 0 (2 hours before the inoculation)
and continuing up to day 2 (early administration) or starting at day 3 after the inoculation and continuing up to day 13 (late administration).
(f) Colony-forming units recovered from the kidney of individual mice at day 3 after infection. Each dot represents an individual mouse. Data
were analyzed by Student’s t test (n ¼ 5 mice per group). (g) Representative images of Sirius red–stained kidney sections., taken at the
corticomedullary junction. Arrows show area positively stained with Sirius red. Bar ¼ 100 mm. (h) Quantiﬁcation of Sirius red staining in kidney
sections of the mice in panel (g). Data were analyzed by Student’s t test (20–35 viewing ﬁelds [1.92 mm2 per ﬁeld] from 5–7 mice per group).
(i) Colony-forming units recovered from the kidney of individual mice at day 14 after infection. Each dot represents an individual mouse. Data
were analyzed by Student’s t test (n ¼ 7 mice per group). *P < 0.05, **P < 0.005, ***P < 0.001.
N Choudhry et al.: C5aR1 in chronic inﬂammation and renal ﬁbrosis ba s i c re sea r chantagonizing the proﬁbrotic actions of transforming growth
factor-b.35 Although the role for collagen IV in renal ﬁbrosis
is not well deﬁned, upregulation of intrarenal expression of
collagen IV mRNA was found to be associated with reducedKidney International (2016) 90, 540–554renal ﬁbrosis in a unilateral ureteral obstruction model,36 thus
supporting an antiﬁbrotic role for collagen IV in renal
ﬁbrosis. Our ﬁnding that C5aR1 has opposing effects on renal
expression of proﬁbrogenic and antiﬁbrogenic factors551
Table 1 | C5a/C5aR1 interaction ampliﬁes bacteria-induced production of proinﬂammatory and proﬁbrogenic factors by RTEC
and MO/MF
mRNA
RTECsa MO/MFsa
C5a UPEC C5a/UPEC C5a UPEC C5a/UPEC
TNF-a 1.1  0.1 5.1  1.2c 17.4  3.3c,e 1.1  0.3 4.0  1.0b 6.7  1.0b,e
IL-6 2.0  0.1b 48.3  9.9c 77.3  8.7d,e 2.9  1.9 14.8  3.1c 34.2  5.4c,e
MCP 1.9  0.3b 48.2  8.3d 78.1  10.1c,e 2.1  0.4b 2.7  0.5b 4.6  0.6d,e
KC 1.2  0.1 14.1  2.8c 121.1  16.1d,e 1.8  0.2b 1.9  0.1b 6.9  1.5b,e
TGF-b 1.2  0.2 0.8  0.3 2.8  0.7b,e 2.2  0.4b 1.8  0.2b 5.7  0.9c,e
PDGF 1.4  0.2 1.0  0.2 3.5  0.6c,e 1.4  0.2 1.4  0.2 4.2  0.7c,e
Ca5R1, C5a receptor 1; IL-6, interleukin-6; KC, keratinocyte-derived protein chemokine; MCP, monocyte chemoattactant protein-1; MO/MF, monocyte/macrophage; PDGF,
platelet-derived growth factor; RTEC, renal tubular epithelial cell; TGF-b, transforming growth factor-b; TNF-a, tumor necrosis factor-a; UPEC, uropathogenic Escherichia coli.
aPrimary cultured RTECs and freshly prepared peritoneal MO/MFs from wild-type mice were incubated with heat-killed UPEC and C5a, alone and combined, for 24 hours and
subjected to reverse transcriptase polymerase chain reaction analysis. mRNA expression was expressed as fold change over the control (absence of C5a and UPEC). Superscript
letters b–d indicate signiﬁcant difference versus control (bP < 0.05 cP < 0.005 dP < 0.001).
eSigniﬁcant difference versus UPEC alone (P < 0.05). Data were analyzed by Student’s t test (n ¼ 5 per group). A representative of 3 independent experiments is shown.
bas i c re sea r ch N Choudhry et al.: C5aR1 in chronic inﬂammation and renal ﬁbrosissupports the concept that C5aR1 inﬂuences the dynamic
balance between tissue destruction and repair after renal
infection, favoring the promotion of tissue destruction and
impairing the repair process.
To conclude, this study is the ﬁrst to deﬁne a novel and
important role of C5aR1 in the pathogenesis of experimental
chronic pyelonephritis. It also suggests that C5aR1-dependent
enhancement of UPEC colonization of renal tract epithelium
and excessive local inﬂammatory responses, as well as
impairment of phagocytic function of phagocytes, contribute
to the chronic inﬂammation and renal ﬁbrosis. Our obser-
vation that blocking the C5a/C5aR1 axis curtailed the pa-
thology suggests a therapeutic potential for targeting C5aR1
in chronic kidney infection. Although antibiotics can be used
to treat the UTI, there is the emerging threat of multidrug-
resistant gram-negative bacteria in urology in addition to
the well-known frequent recurrence and persistence of
infection. Targeting the C5a/C5aR1 axis may offer alternative
or combination therapies to reduce the use of antibiotics.a 
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552METHODS
Mice
Homozygous C5aR1-/- mice were generated by homologous
recombination in embryonic stem cells37 and backcrossed onto the
C576BL/6 (H-2b) parental strain for at least 12 generations. C5aR1-/-
mice and their WT littermates were used in all experiments, and
animal procedures were carried out in accordance with the Animals
Scientiﬁc Procedures Act 1986.Induction of chronic pyelonephritis
A previously described model of ascending UTI leading to chronic
pyelonephritis was used. The infection was induced in WT and
C5aR1-/- mice (females 8–10 weeks old) by bladder inoculation of
the human UPEC strain IH11128 (108 CFUs in 50 ml phosphate-
buffered sailine) per urethram. The IH11128 strain (075:K5:H–)
was isolated from patients with chronic pyelonephritis. It is a
mannose-resistant strain expressing both Dr and type 1 ﬁmbriae but
lacking P ﬁmbriae and hemolytic activity (a kind gift from Dr. B.
Nowicki, University of Texas, Galveston, Texas, USA).38 Mice were
killed at day 2, day 14, and day 56 after infection for evaluatingb 
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rarhodamine isothiocyanate–labeled IH11128 was used for imaging
bacteria in kidney sections. For C5aR1 antagonist treatment exper-
iments, WT mice were administered C5aR1 peptide antagonist
(PMX53, Ac-Phe-cyclo[Orn-Pro-dCha-Trp-Arg]) or control agent
(random sequence peptide) (synthesized by GenScript, Shanghai,
China) by subcutaneous injection (1 mg/kg daily) starting at
different stages of infection and for different times.
Assessment of renal histopathological features
Parafﬁn sections (4 mm) were stained with hematoxylin and eosin,
periodic acid–Schiff stain, or Sirius red. Stained kidney sections were
scanned with a Hamamatsu Nanozoomer 2.0 HT slide scanner
(Hamamatsu Photonics, Hamamtsu, Japan) and viewed using
NDP.view2 software. Renal histopathological changes were assessed
on periodic acid–Schiff– and hematoxylin and eosin–stained sections
using a 6-point scale in which 0, 1, 2, 3, 4, and 5 indicated normal,
very little, very mild, mild, moderate, and severe histological lesions,
respectively. The assessment was based on histopathological changes
(i.e., cellular inﬁltration, tubular atrophy, and interstitial inﬂam-
mation) that were mainly located at the corticomedullary junction
area. Renal ﬁbrosis was assessed on Sirius red–stained sections. The
positively stained areas were quantiﬁed by imaging analysis (ImageJ
software; National Institutes of Health, Bethesda, MD, USA). Brieﬂy,
6 to 8 corticomedullary junction viewing ﬁelds selected from
appropriate areas within each kidney were examined. Positively
stained areas were expressed as a percentage of the whole ﬁeld area
(1.92 mm2). All the aforementioned quantitative analyses were
performed in a blinded fashion by 2 experienced persons.
Measurement of bacterial load in the kidney and bladder
Total bacterial load in kidney and bladder tissue was measured by the
agar plate assay as previously described, with modiﬁcations.26 In
brief, the tissue was weighed and subsequently homogenized in 2 ml
(for the kidney) or 1 ml (for the bladder) of phosphate-buffered
saline. A quantity of 100 ml of a series dilution of homogenates
were plated on cysteine-, lactose-, and electrolyte-deﬁcient plates.
After incubation of the plates for 24 hours, bacterial CFUs on the
agar plates were manually counted and expressed as CFU per gram of
tissue.
Statistical analysis
Data are shown either as the mean  SEM or the readout of indi-
vidual mice. Unpaired Student’s t test was used for comparison be-
tween two groups. All the analyses were performed using Graphpad
Prism Software version 5 (GraphPad Software, LaJolla, CA, USA).
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